MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.
MitoRx Therapeutics's investors include Future Planet Capital, Empirical Ventures, Longevitytech.fund, UK Innovation & Science Seed Fund, Wren Capital.
MitoRx Therapeutics is headquartered in Harwell, United Kingdom.
MitoRx Therapeutics is a biotechnology company developing novel therapeutics that reverse mitochondrial dysfunction.
MitoRx Therapeutics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MitoRx Therapeutics — Funding & Investors." VCBacked, November 1, 2024, https://www.vcbacked.co/company/mitorx-therapeutics. Accessed August 14, 2026.
VCBacked. (2024). MitoRx Therapeutics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/mitorx-therapeutics
{{cite web |title=MitoRx Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mitorx-therapeutics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated